Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review

@article{Molero2018AntidepressantEA,
  title={Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review},
  author={P. Molero and J. Ramos-Quiroga and R. Mart{\'i}n-Santos and E. Calvo-S{\'a}nchez and L. Guti{\'e}rrez-Rojas and J. Meana},
  journal={CNS Drugs},
  year={2018},
  volume={32},
  pages={411-420}
}
Ketamine and its enantiomer S-ketamine (esketamine) are promising candidates to produce a rapid-onset antidepressant effect in treatment-resistant depression. Ketamine causes continued blockade of the glutamate N-methyl-d-aspartate (NMDA) receptor, though this might not primarily mediate the antidepressant effect. Alternative hypotheses include selectivity for the NMDA receptor subtype containing the NMDA receptor subunit 2B (NR2B), inhibition of the phosphorylation of the eukaryotic elongation… Expand
71 Citations
Repurposing Potential of Ketamine: Opportunities and Challenges
  • 3
Rapid-Acting Antidepressants.
  • 19
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
  • 43
  • PDF
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?
Ketamine in the Treatment of Depressive Episodes.
  • 2
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 58 REFERENCES
Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.
  • 117
  • PDF
Mechanisms of ketamine action as an antidepressant
  • 203
  • PDF
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
  • 276
Convergent Mechanisms Underlying Rapid Antidepressant Action
  • 76
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
  • 780
  • Highly Influential
  • PDF
Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
  • 179
  • PDF
Ketamine for Treatment-Resistant Unipolar Depression
  • 95
Ketamine for Depression, 5: Potential Pharmacokinetic and Pharmacodynamic Drug Interactions.
  • C. Andrade
  • Medicine
  • The Journal of clinical psychiatry
  • 2017
  • 24
Mechanistic Target of Rapamycin–Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model
  • 97
ON or OFF?: Modulating the N-Methyl-D-Aspartate Receptor in Major Depression
  • 17
...
1
2
3
4
5
...